The rising popularity in GLP-1 agonists for diabetes has led to a discussion about application forms : transdermal systems versus pills . Usually , GLP-1 therapies were only available in pill form, but https://dawudivoy747862.myparisblog.com/41488659/glp-1-skin-applications-vs-tablets-what-suitable-for-the-patient